Elena Tatarov

Elena Tatarov serves as a key procurement professional within the FDA Office of Acquisition and Grant Services, supporting the agency’s mission to safeguard public health through the acquisition of critical scientific and analytical resources. She manages a diverse portfolio of contracts focused on high-precision laboratory instrumentation, regulatory science services, and specialized research support, ensuring the FDA maintains cutting-edge capabilities in drug safety evaluation, biological product testing, and medical device validation. Her work directly enables the agency’s regulatory science infrastructure by securing mission-critical goods and services that underpin scientific decision-making and compliance oversight. Tatarov maintains consistent working relationships with specialized contractors including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc., and Progenics Pharmaceuticals Inc., reflecting a preference for niche providers with deep expertise in preclinical research, toxicology, and pharmaceutical development services. These partnerships are typically formed through competitive sealed bidding and requirements-driven solicitations, emphasizing technical capability, regulatory compliance, and quality assurance standards aligned with FDA guidance. Her contracting approach prioritizes vendors with proven experience in regulated environments and demonstrated ability to deliver under strict scientific and operational protocols. Her procurement patterns show a strong emphasis on open competition, with 80.5% of awards issued without set-aside designations, indicating a focus on technical merit and market-wide competition. Nevertheless, she actively supports small business participation, with nearly 20% of awards directed toward Total Small Business Set-Asides under FAR 19.5, reflecting a balanced commitment to both efficiency and socioeconomic goals. Her primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing), where she acquires advanced mass spectrometers, chromatography systems, and other high-performance analytical equipment essential for regulatory testing. She also procures professional scientific services under NAICS 541990, supporting specialized research, data analysis, and laboratory operations critical to the FDA’s scientific mission.